These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 23272099)
1. Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction. Barakat KH; Jordheim LP; Perez-Pineiro R; Wishart D; Dumontet C; Tuszynski JA PLoS One; 2012; 7(12):e51329. PubMed ID: 23272099 [TBL] [Abstract][Full Text] [Related]
2. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy. Gentile F; Tuszynski JA; Barakat KH J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH. Saijo M; Matsuda T; Kuraoka I; Tanaka K Biochem Biophys Res Commun; 2004 Sep; 321(4):815-22. PubMed ID: 15358100 [TBL] [Abstract][Full Text] [Related]
4. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells. Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347 [TBL] [Abstract][Full Text] [Related]
5. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins. Jiang H; Yang LY Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501 [TBL] [Abstract][Full Text] [Related]
6. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways. Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136 [TBL] [Abstract][Full Text] [Related]
7. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif. Fadda E Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523 [TBL] [Abstract][Full Text] [Related]
9. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin. Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280 [TBL] [Abstract][Full Text] [Related]
10. Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach. Barakat KH; Torin Huzil J; Luchko T; Jordheim L; Dumontet C; Tuszynski J J Mol Graph Model; 2009 Sep; 28(2):113-30. PubMed ID: 19473860 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition. Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758 [TBL] [Abstract][Full Text] [Related]
12. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA. Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053 [TBL] [Abstract][Full Text] [Related]
13. Mitotic regulator Nlp interacts with XPA/ERCC1 complexes and regulates nucleotide excision repair (NER) in response to UV radiation. Ma XJ; Shang L; Zhang WM; Wang MR; Zhan QM Cancer Lett; 2016 Apr; 373(2):214-21. PubMed ID: 26805762 [TBL] [Abstract][Full Text] [Related]
14. DNA repair gets physical: mapping an XPA-binding site on ERCC1. Croteau DL; Peng Y; Van Houten B DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein. Nagai A; Saijo M; Kuraoka I; Matsuda T; Kodo N; Nakatsu Y; Mimaki T; Mino M; Biggerstaff M; Wood RD Biochem Biophys Res Commun; 1995 Jun; 211(3):960-6. PubMed ID: 7598728 [TBL] [Abstract][Full Text] [Related]
16. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2. Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348 [TBL] [Abstract][Full Text] [Related]
17. Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions. Rademakers S; Volker M; Hoogstraten D; Nigg AL; Moné MJ; Van Zeeland AA; Hoeijmakers JH; Houtsmuller AB; Vermeulen W Mol Cell Biol; 2003 Aug; 23(16):5755-67. PubMed ID: 12897146 [TBL] [Abstract][Full Text] [Related]
18. Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair. Li L; Peterson CA; Lu X; Legerski RJ Mol Cell Biol; 1995 Apr; 15(4):1993-8. PubMed ID: 7891694 [TBL] [Abstract][Full Text] [Related]
19. Metal binding mediated conformational change of XPA protein:a potential cytotoxic mechanism of nickel in the nucleotide excision repair. Hu J; Hu Z; Zhang Y; Gou X; Mu Y; Wang L; Xie XQ J Mol Model; 2016 Jul; 22(7):156. PubMed ID: 27307058 [TBL] [Abstract][Full Text] [Related]
20. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction. Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]